title: The Nidoviruses (Coronaviruses and Arteriviruses) (Advances in Experimental Medicine & Biology)
author: Ehud Lavi
description: <strong>'</strong>The quality of the presentations is excellent. This book should be studied by every 'RNA virologist', but the intricate replication strategies and other features of these viruses are of general interest to all virologists. [..]worth the expense and is highly recommended.<strong>'</strong><br /> <strong>Microbiology Today, August (2002)</strong>
zlib_text: Science & Society
  Neutralizing Antibodies
  against SARS-CoV-2
  and Other Human
  Coronaviruses
  Shibo Jiang,1,2
  Christopher Hillyer,1 and
  Lanying Du1,*
  Coronavirus (CoV) disease 2019
  (COVID-19) caused by severe acute
  respiratory syndrome (SARS)-CoV-
  2 (also known as 2019-nCoV) is
  threatening global public health,
  social stability, and economic de-
  velopment. To meet this challenge,
  this article discusses advances in
  the research and development of
  neutralizing antibodies (nAbs) for
  the prevention and treatment of
  infection by SARS-CoV-2 and other
  human CoVs.
  Current Situation with SARS-CoV-2
  and Other Human CoVs
  Three emerging, highly pathogenic human
  CoVs are SARS-CoV, Middle East respira-
  tory syndrome (MERS)-CoV, and COVID-
  19 virus, which was previously named
  2019-nCoV by the World Health Organiza-
  tion (WHO), and is also known as hCoV-19
  or SARS-CoV-2 [1]. Atypical pneumonia
  (SARS) was ﬁrst reported from Guangdong
  Province, China in late 2002. SARS caused
  a global pandemic in 2003 with